KLK3 and Familial prostate cancer: A combination of the high prevalence of prostate cancer and the poor diagnostic accuracy of the prostate-specific antigen (PSA) underscores the importance of diagnosis methods and calls out for further attempts to improve (reduce) their performance (cost).